Diving Deep into the Abdominal Cavity
Dr. Rebecca Auer holds a Catalyst Grant from BioCanRx to test the use of immunotherapy to treat peritoneal carcinomatosis. Her work on this project is intended to get the evidence needed to proceed to clinical trials and, she says, it’s looking promising.
John Bell Wins Inaugural ESGCT Public and Patient Engagement Award
BioCanRx is pleased to announce that Scientific Director Dr. John Bell has won the the inaugural European Society for Gene and Cell Therapy (ESGCT) Public and Patient Engagement Award.
BioCanRx Cycle II LOI Call
BioCanRx recently announced a Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of our Cycle II application to the federal government’s Networks of Centres of Excellence (NCE) Program. The deadline for applications is May 1st, 2019.